News

HPQ Silicon Achieves Milestone with First ENDURA+ Battery Shipments

HPQ Silicon Achieves Milestone with First ENDURA+ Battery Shipments

HPQ Silicon Celebrates First Industrial Shipments of ENDURA+ Batteries

HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08) has reached a noteworthy milestone with the arrival of its first industrial shipments of the innovative HPQ ENDURA+ lithium-ion battery cells. This shipment marks a significant step in HPQ's ambition to revolutionize energy storage technology.

Overview of the Shipment and Technology

Last week, HPQ received the shipment at its Montreal office, which includes advanced cylindrical battery formats, specifically the commonly used 18650 and 21700 sizes. These batteries incorporate HPQ's cutting-edge GEN3 silicon-based anode material, which was co-developed with Novacium, a European leader in cleantech innovation.

Transition to Real-World Testing

This initial batch of pre-commercial battery cells represents a critical transition from laboratory testing to real-world applications. HPQ plans to distribute these units to selected industry partners and institutional testers in sectors such as mobility, energy storage, and defense. This independent field testing will occur under a variety of operating conditions to gather essential performance data.

Significance of the Milestone

The delivery of the ENDURA+ cells is not just about logistics; it signifies a bridge between HPQ’s research and actual market readiness. Bernard Tourillon, President and CEO of HPQ Silicon, emphasized that this achievement enables the company to deliver their battery technology directly to end users and testing partners. By doing so, they will be able to verify performance consistency and refine the technology as they move towards full-scale commercialization.

Market Validation Steps

The HPQ ENDURA+ cells have already shown promising results in extensive lab trials conducted throughout previous years. With demonstrated electrochemical stability and a high energy density, these battery cells are not only technologically advanced but also compatible with existing lithium-ion production infrastructure. This adaptability is crucial for scaling production to meet global market demands.

Advancing North American Battery Technology

In collaboration with Novacium SAS, HPQ has developed its GEN3 silicon-anode technology, which is built to enhance energy density and cycle life, offering a competitive edge in the battery market. HPQ’s long-term vision involves establishing a high-value battery material production facility in Canada, which will significantly strengthen North American supply chains for advanced energy storage solutions.

Upcoming Developments and Strategy

As testing progresses, HPQ intends to keep investors and partners informed about performance results, certification achievements, and updated production timelines. The company is dedicated to transparency and proactive communication throughout this crucial phase of development.

About HPQ Silicon

HPQ Silicon Inc. is focused on developing innovative solutions in advanced materials and critical processes. Collaborating closely with Novacium, HPQ is pushing the envelope with next-generation silicon-based anode materials and sustainable technologies such as clean hydrogen and waste-to-energy systems. These initiatives are essential for addressing global net-zero goals.

Alongside its battery development, HPQ is working on proprietary processes aimed at creating a low-cost, zero-CO? footprint production of fumed silica and high-purity silicon, backed by technical support from partner PyroGenesis Inc.

Frequently Asked Questions

What is the significance of the recent battery shipment for HPQ?

The shipment represents a major step towards commercialization, allowing for real-world testing of HPQ's battery technology.

What types of batteries were included in the shipment?

The shipment included the 18650 and 21700 cylindrical battery formats, both utilizing advanced silicon-based anode materials.

How will these batteries be tested in the market?

HPQ will distribute the cells to selected industry partners for independent field tests under various conditions to evaluate performance.

What is HPQ's long-term goal with its battery technology?

HPQ aims to establish localized battery material production in Canada to enhance North American supply chains and support sustainable energy solutions.

Who can I contact for further information about HPQ Silicon?

For more information, please reach out to Bernard J. Tourillon, the Chairman, President, and CEO, at +1 (514) 846-3271 or via email at Info@hpqsilicon.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Liberty Hill: 50 Years of Grassroots Revolution

Updated Category News Views 4

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 6

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
Red-Eye Flights Surge, Driven By Western U.S. Routes

Updated Category News Views 5

You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...

Continue Reading
Rare Collectibles Highlight Morphy's Auction on Oct 4

Updated Category News Views 2

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

Continue Reading
AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 10

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 3

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 3

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 2

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 13

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 5

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading

Top 5 Most Recently Viewed Articles

UK's Public Sector Deficit Grows Amid Rising Debt Concerns

Updated Category News Views 258

Understanding the Growing UK Budget Deficit The recent data revealed a significant increase in the UK’s budget deficit, raising concerns regarding the country's fiscal management. With borrowing hitting 17.8 billion pounds, which is approximately $21.93 billion in December, this figure surpassed previous expectations and highlighted the growing financial strain on the...

Continue Reading
Masimo Achieves New Stock Milestone with Exciting Growth

Updated Category News Views 151

Masimo Corporation Reaches New Heights in Stock Performance Masimo Corporation (NASDAQ: MASI), a leading global medical technology company, has made headlines by reaching a remarkable 52-week high, with its stock valued at an impressive $173.91. This notable achievement signifies a robust upward trend within the market, showcasing an extraordinary 1-year growth change of...

Continue Reading
Discover Cutting-Edge Coding Solutions at Pack Expo 2024

Updated Category News Views 77

Videojet Showcases Solutions at Pack Expo 2024 At Pack Expo 2024, Videojet Technologies, a leader in coding, marking, and printing solutions, will present an array of innovative products tailored to enhance the efficiency of packaging operations. This year's event will take place at McCormick Place, booth S-2030, from November 3 to 6. The company is eager to connect with...

Continue Reading
BioNTech Reaches $1.25 Billion Settlement Over Vaccine Royalties

Updated Category News Views 190

BioNTech's Settlements: A Closer Look BioNTech, the renowned German biotechnology firm known for its role in developing the COVID-19 vaccine alongside Pfizer, has recently made headlines with two significant settlement agreements. The company announced that it has entered into these agreements with the U.S. National Institutes of Health and the University of Pennsylvania...

Continue Reading
Rado's Anatom Collection: A Seasonal Revamp for Everyone

Updated Category News Views 138

A Fresh Evolution of Rado's Design Icon As the summer season approaches, Rado is thrilled to introduce three captivating new versions of its iconic Anatom timepiece. These refreshed models, available globally, embody a perfect blend of modern design and enduring craftsmanship. Originally launched in the early 80s, the Anatom timepiece was revolutionary, introducing...

Continue Reading